What a Capability Statement Is — and Is Not

A capability statement is not a marketing brochure. It is a structured, factual document that answers the evaluator's specific question: 'Is this supplier qualified to supply what we need?' The evaluator is typically a procurement manager, a technical committee, or a regulatory affairs officer — and they are looking for specific objective evidence: regulatory compliance documentation, quality system certification, manufacturing capacity, clinical track record, and financial stability indicators. A capability statement that is heavy on marketing language ('Turkey's leading manufacturer of...', 'world-class quality...', 'trusted by hospitals globally...') and light on documented evidence will fail in any sophisticated tender evaluation. The capability statement must be evidence-dense, factually precise, and structured to address the tender's specific evaluation criteria — not a generic company brochure with a cover letter attached.

The Essential Structure of a Medical Device Capability Statement

A medical device capability statement for international tenders should follow this structure: (1) Company Overview — founding year, ownership, employee count, annual revenue (or export revenue), manufacturing location and certifications; (2) Product Portfolio — the specific products being offered for this tender, with catalogue numbers, technical specifications, and CE classification; (3) Regulatory Credentials — CE marking certificates (with Notified Body name and number), ISO 13485 certificate (scope and certification body), national registrations relevant to the tender market (SFDA, MOHAP, ANMAT, etc.), and TITCK Free Sale Certificate; (4) Quality System — brief description of QMS scope, post-market surveillance processes, and complaint handling procedure; (5) Manufacturing Capacity — annual production volumes, clean room classifications for sterile products, sterilisation method and validation, quality control testing infrastructure; (6) Clinical Track Record — which hospitals or health systems currently use your products; country reference list; any published clinical data; (7) Financial Stability Indicators — banking references, D&B rating if available, years of operation, insurance coverage; (8) Logistics and Supply Chain — incoterm options, lead times, minimum order quantities, cold chain capability if relevant.

Regulatory Documentation: The Non-Negotiable Core

In a medical device capability statement, regulatory documentation is not a section that can be vague or incomplete. Every certificate cited must be: current (not expired), authentic (from an accredited body), and correctly described (the scope must cover the products being tendered). Common regulatory documentation errors in Turkish manufacturer capability statements: citing CE certificates that have expired; citing ISO 13485 certificates with scopes that do not cover the tendered product categories; providing the CE marking symbol without the certificate; failing to provide the Notified Body name and number; omitting EUDAMED registration confirmation for EU tenders; and providing TITCK Free Sale Certificates with outdated product descriptions. All regulatory certificates should be provided as clear, complete copies (not photos taken on a phone). A checklist review of all certificate validity and scope coverage before any capability statement submission is essential quality control.

Differentiation: What Makes Your Statement Stand Out

Most tender evaluators review multiple capability statements from multiple competing manufacturers. The differentiation elements that make a Turkish manufacturer's capability statement stand out are: clinical reference accounts — named hospitals or health systems (with permission) where your products are currently used, particularly in the same country or region as the tender; quality system depth indicators — not just 'we have ISO 13485' but specific indicators of quality system maturity (number of years certified, number of successful NB surveillance audits, PMS data summary, zero critical non-conformances in the last audit cycle); manufacturing capacity evidence — specific production capacity data, not vague claims ('our annual production capacity for this product is 500,000 units, supported by our 4,000 m² clean room facility'); innovation and development signals — R&D investment percentage, new products launched in the last 3 years, clinical investigations in progress; and sustainability credentials — ISO 14001, carbon footprint data, sustainable packaging certifications for tenders with environmental evaluation criteria.

Adapting the Statement to Each Tender

A capability statement should never be entirely generic — it must be tailored to each tender's specific evaluation criteria. Tender documents always specify evaluation criteria (technical capability, quality systems, pricing, delivery capability, after-sales support, financial stability, local content if applicable). The capability statement must directly address each criterion in the language the evaluator will use to score it. Practical adaptation process: read the tender document's supplier qualification section carefully and highlight each evaluation criterion; map each criterion to the section of your capability statement that addresses it; for criteria not currently addressed in your standard statement, add a specific section; remove sections that are irrelevant to this tender's evaluation criteria (shorter and more focused is better than long and generic); and localise where appropriate — if the tender is from a Saudi government hospital, include SFDA registration confirmation, Arabic IFU confirmation, and a statement about your local agent's credentials.

Common Mistakes That Eliminate Capability Statements

The mistakes that cause capability statement disqualification before evaluation begins: expired certificates — the single most common disqualification; incomplete product specifications — tendered products not fully described with model numbers, dimensions, and performance parameters; missing local market registration — most government tenders require current national product registration in the tendering market; no clinical track record — capability statements with no reference accounts or clinical evidence are treated as unproven; generic marketing language without evidence — claims without documentation are ignored; and poor translation quality — a capability statement with grammatical errors and incorrect medical terminology signals that the manufacturer does not take the tender seriously or does not invest in professional communication.

Conclusion

A winning capability statement is a precision document — every claim evidenced, every certificate current, every section tailored to the specific tender's evaluation criteria, and every page communicating the professional quality that reflects your manufacturing quality. Turkish medical device manufacturers who invest in developing high-quality, regularly updated capability statement infrastructure — and who adapt it systematically for each major tender — will convert their regulatory investments and clinical track records into the shortlist positions where products and prices are compared. The capability statement is where tender wins begin.